£55M UK investment in Cell Therapy manufacturing

See on Scoop.itInteresting Innovation

The Chancellor announced today that, as part of this year’s budget, the Catapult network will benefit from a £74m investment to focus on cell therapy manufacturing and graphene applications.

Ajan Reginald‘s insight:

Good to see this investment in the UK and good momentum with Cell Therapy Catapult.

However – perhaps worth remembering this level of commitment is dwarfed by California CIRM and Japanese initiatives.

See on www.innovateuk.org

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s